Computer-Aided Drug Discovery Market Share, Trends, Future Outlook, Analysis and Forecast 2023-2030

The global computer aided drug discovery market is anticipated to grow at a CAGR of 11.5% during the forecast period. Rising drug discovery and development activities owing to the rising prevalence of infectious and chronic diseases is contributing to the growth of the global computer-aided drug discovery market. Several partnerships for drug discovery and development have been witnessed over the years, which in turn, is boosting the market growth.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/computer-aided-drug-discovery-market

Recent Partnerships for Drug Discovery

September 2021- Huadong Medicine and Insilico Medicine entered into a co-development agreement to accelerate the discovery of breakthrough small-molecule therapeutics by leveraging an innovative approach in the oncology field. Under the collaboration, Insilico and Huadong Medicines launched a new drug discovery project involving the R&D team of both parties. The collaboration will leverage Huadong Medicine's advanced innovative drug discovery in combination with Insilico's end-to-end AI-driven rug discovery platform. The project leads to hit undruggable targets that regulate tumor growth.

May 2022- SOM biotech announced that it has signed a licensing agreement with the Ministry of Minnesota. With this collaboration, the University of Minnesota conducted a series of in vitro studies on potential pre-clinical product candidates for Duchenne and Becker muscular dystrophy identified using SOM Biotech's exclusive platform, SOMAIPRO. Somaipro assists in identifying drugs effective for the treatment of a specific disease, discovering new mechanisms of action and new applications for a drug, and predicting the toxicity of the compounds, as well as the molecular scaffolds for compounds active on a given target. While other AI-based approaches use methods based on data mining, structural similarity, or the target structure, SOMAIPRO uses molecular fields, allowing for an increased rate of success, with results achieved in the shortest possible time and considerably reducing the costs associated with drug discovery.

Global Computer-Aided Drug Discovery Market Report by Segment

By Type

Structure-Based Drug Design
Ligand-Based Drug Design
Sequence-Based Approaches

By Therapeutic Area

Oncology
Neurology
Cardiovascular Disease
Respiratory Disease
Diabetes

By End-User

Pharmaceutical Companies
Biotechnology Companies
Research Laboratories

A full report of Computer-Aided Drug Discovery Market is available at: https://www.omrglobal.com/industry-reports/computer-aided-drug-discovery-market

Computer-Aided Drug Discovery Market- Segment by Region

North America

United States
Canada

Europe

Germany
United Kingdom
France
Spain
Italy
Rest of Europe

Asia-Pacific

China
Japan
India
Rest of Asia-Pacific

Rest of the World

Middle East & Africa
Latin America

Company Profiles

Aris Pharmaceuticals Inc.
ArrayGen Technologies Pvt. Ltd.
BioDuro- Sundia
BOC Sciences
Nimbus Therapeutics
Oxford Drug Design
Pharmaron
Profacgen
WuXi AppTec

Reasons to Buying From us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.